How to Get AndroGel in Massachusetts

What AndroGel Is and Why Massachusetts Residents Need a Prescription

AndroGel is a topical hydroalcoholic testosterone gel applied to the shoulders, upper arms, or abdomen once daily. The FDA approved the 1% formulation in 2000 and the higher-concentration 1.62% formulation in 2011, both manufactured by AbbVie. [1] Because testosterone is a Schedule III controlled substance under the Controlled Substances Act, every dispensed unit requires a valid prescription from a licensed prescriber with DEA authority. [2]

Male hypogonadism, the primary indication for AndroGel, affects an estimated 2 to 6 million men in the United States. [3] The condition is defined by the Endocrine Society's 2018 Clinical Practice Guideline as a combination of consistent symptoms and unambiguously low serum testosterone on at least two morning measurements. [4] Symptoms include low libido, fatigue, reduced muscle mass, and depressed mood, but those symptoms alone are not sufficient to justify a prescription under Massachusetts standard of care. The prescriber must confirm biochemical hypogonadism before writing the first script.

Massachusetts law treats testosterone identically to other Schedule III substances. Prescriptions may be issued for up to a 90-day supply, and refills require an ongoing prescriber-patient relationship with documented monitoring. [5] The Massachusetts Prescription Monitoring Program (PMP) tracks every dispensed controlled substance, so prescribers check the PMP before writing and pharmacists check it before dispensing.

Step-by-Step: Getting an AndroGel Prescription in Massachusetts

Getting AndroGel in Massachusetts follows a five-step sequence that applies whether you use a brick-and-mortar clinic or a telehealth platform.

Step 1. Order baseline labs. Before your first appointment, you need at minimum: total serum testosterone (two separate morning draws, ideally one week apart), luteinizing hormone (LH), follicle-stimulating hormone (FSH), sex hormone-binding globulin (SHBG), complete blood count (CBC) with hematocrit, PSA (men 40 and older), and a basic metabolic panel. [4] Many telehealth platforms let you order these through LabCorp or Quest Diagnostics before the video visit so the prescriber can review results during the appointment. [6]

Step 2. Complete a clinical consultation. The prescriber reviews your labs, medical history, medications, and symptoms. They must document that your testosterone is below the laboratory's lower reference limit on two occasions and that symptoms are consistent with hypogonadism. The Endocrine Society guideline explicitly states: "We recommend against making a diagnosis of androgen deficiency in men with acute or subacute illness." [4] That means active infection, recent surgery, or severe stress can suppress testosterone transiently and must be ruled out.

Step 3. Receive the prescription and choose a pharmacy. Massachusetts prescribers may transmit controlled-substance prescriptions electronically to retail pharmacies via EPCS (Electronic Prescribing of Controlled Substances), which Massachusetts adopted as mandatory for most controlled substances. [7] You can fill AndroGel at any retail pharmacy (CVS, Walgreens, Rite Aid, independent), use a mail-order pharmacy, or transfer to a 503A compounding pharmacy for a lower-cost testosterone gel.

Step 4. Complete prior authorization if using insurance. Most commercial plans and MassHealth (Massachusetts Medicaid) require PA before covering brand-name AndroGel. PA documentation typically includes lab values, ICD-10 code E29.1 (testicular hypofunction), and the prescriber's clinical notes. [8]

Step 5. Begin therapy and schedule follow-up labs. The Endocrine Society recommends checking serum testosterone three to six months after starting therapy to confirm levels are in the mid-normal range (400 to 700 ng/dL), along with hematocrit and PSA. [4] If hematocrit exceeds 54%, the prescriber must reduce the dose or discontinue therapy. [9]

Telehealth AndroGel Prescribing in Massachusetts

Massachusetts permits telehealth prescribing of controlled substances, including testosterone, under specific conditions. The Massachusetts Board of Registration in Medicine requires that a valid prescriber-patient relationship exist, that the prescriber hold a current Massachusetts license, and that the prescriber have sufficient clinical information to make a diagnosis. [10] A synchronous audio-video visit typically satisfies the relationship requirement; asynchronous (store-and-forward) visits alone are generally not sufficient for Schedule III substances.

The DEA's 2023 proposed rules for telemedicine prescribing of controlled substances would have required an in-person visit before remote prescribing, but the DEA extended the COVID-era telemedicine flexibilities through December 31, 2025, allowing established telehealth-only prescribing of Schedule III substances to continue while final rules are promulgated. [11] Massachusetts telehealth platforms operating under these flexibilities can legally prescribe AndroGel to Massachusetts residents without a prior in-person visit, as long as the prescriber holds a Massachusetts license and a valid DEA registration.

Several national TRT telehealth platforms have Massachusetts-licensed physicians on staff and can prescribe testosterone gel to Massachusetts residents. A typical telehealth workflow runs as follows: online symptom intake, lab order sent to a local draw site, synchronous video visit (15 to 30 minutes), prescription transmitted electronically to your chosen pharmacy. Total time from intake to prescription is commonly 5 to 10 business days. [12]

The T-Trials, a coordinated set of seven placebo-controlled trials (N=790 men aged 65 and older with total testosterone below 275 ng/dL), demonstrated that testosterone gel raised serum testosterone to mid-normal levels and produced statistically significant improvements in sexual function, walking distance, and bone density over 12 months. [13] The sexual-function trial showed a mean improvement of 0.58 points on the Psychosexual Daily Questionnaire (PDQ) score versus 0.13 for placebo (P<0.001). [13] This evidence base is what modern prescribing guidelines point to when defining treatment candidacy.

Labs Required Before AndroGel in Massachusetts

No Massachusetts prescriber operating within the standard of care will write an AndroGel prescription without confirmed biochemical hypogonadism. The minimum required labs are specific and the rationale for each is well established.

Total testosterone (two morning draws). Testosterone follows a circadian rhythm, peaking between 8 and 10 a.m. Levels drawn after noon can be 20 to 30% lower than morning peaks in healthy men. [14] The Endocrine Society defines hypogonadism as a total testosterone consistently below 300 ng/dL in the presence of symptoms. [4] Both draws must be done fasting, before 10 a.m., on separate days at least 48 hours apart.

LH and FSH. These gonadotropins distinguish primary hypogonadism (testicular failure, with elevated LH/FSH) from secondary hypogonadism (pituitary or hypothalamic origin, with low or inappropriately normal LH/FSH). The distinction changes clinical management: secondary hypogonadism with low LH may indicate a pituitary mass requiring MRI before starting testosterone. [4] Prescribing AndroGel without LH/FSH is clinically substandard and most Massachusetts prescribers will not do it.

SHBG. Because only free testosterone is biologically active, SHBG levels influence how much free testosterone is available. Men with high SHBG may have low free testosterone despite a total testosterone above 300 ng/dL. Some guidelines support treating symptomatic men with low free testosterone even when total testosterone is borderline. [15]

Hematocrit (CBC). Testosterone stimulates erythropoiesis. Baseline hematocrit above 50% is generally a contraindication to starting therapy due to the risk of polycythemia and thromboembolism. [9] The FDA product label for AndroGel lists polycythemia as a risk requiring monitoring. [1]

PSA (men 40 and older). Testosterone can accelerate growth of pre-existing prostate cancer. The Endocrine Society recommends baseline PSA before starting therapy in men 40 and older, with a PSA above 4.0 ng/mL or a PSA velocity exceeding 1.4 ng/mL per year prompting urology referral before prescribing. [4]

Comprehensive metabolic panel. Liver function and kidney function baselines are standard before starting any long-term hormonal therapy and are required by most insurers for PA. [8]

A 2020 retrospective study published in the Journal of Urology (N=3,714 men) found that 35% of men who had received a testosterone prescription in a primary-care setting had not had two confirming testosterone measurements before the first prescription was written, a gap that increases the likelihood of PA denial and potential prescribing errors. [16]

Pharmacy Options for AndroGel in Massachusetts

Massachusetts residents can fill an AndroGel prescription at several types of pharmacies, and the cost difference between them is substantial.

Retail pharmacies. CVS, Walgreens, and Rite Aid all stock AndroGel 1% (75 g pump) and AndroGel 1.62% (75 g pump). Without insurance, brand-name AndroGel 1.62% runs approximately $400 to $600 per month at retail. GoodRx and similar discount cards can reduce that to $80 to $150 per month at some locations, though prices vary by zip code within Massachusetts.

Mail-order pharmacies. Most commercial insurance plans allow 90-day mail-order fills for maintenance medications, including testosterone. Express Scripts and CVS Caremark are the two largest PBMs used by Massachusetts employer plans. Mail order typically reduces the per-unit cost by 15 to 25% versus retail.

503A compounding pharmacies. Massachusetts is a member state that permits licensed 503A pharmacies to compound testosterone gel for individual patients when a prescriber documents a clinical rationale. [17] Compounded testosterone gel (typically 10 mg/mL or 20 mg/mL in a hydroalcoholic base) can cost $40 to $80 per month without insurance, a fraction of the brand-name cost. The prescriber must specify the exact concentration, base, and quantity on the compounding prescription. Compounded testosterone is not FDA-approved, meaning it has not gone through the same manufacturing and potency verification process as AndroGel. [17]

Massachusetts 503A pharmacies must be licensed by the Massachusetts Board of Registration in Pharmacy and must comply with USP Chapter 795 standards for non-sterile compounding. [18] Out-of-state 503A pharmacies can also ship to Massachusetts patients if they hold a Massachusetts non-resident pharmacy license; NABP's database of accredited compounders is one resource for verifying licensure. [19]

MassHealth (Medicaid) coverage. MassHealth covers brand-name AndroGel for male hypogonadism with prior authorization. The PA requires documented serum testosterone below 300 ng/dL on two separate draws, ICD-10 E29.1, and confirmation that the prescriber has ruled out secondary causes. MassHealth may also cover generic testosterone gel (authorized generics from Perrigo and Lannett) with less restrictive PA criteria. [8]

Prior Authorization in Massachusetts: What Documents You Need

Prior authorization for AndroGel through Massachusetts commercial insurers and MassHealth follows a predictable template, but the documentation burden is real. Gathering the right materials before the PA is submitted reduces delays from the typical 3 to 5 business days to same-day or next-day approval in many cases.

Standard PA documentation includes: [8]

• Both morning testosterone lab results with reference ranges, dates, and the drawing facility's CLIA number
• LH and FSH results
• PSA result (if the patient is 40 or older)
• Hematocrit or CBC result
• The prescriber's clinical note confirming symptomatic hypogonadism
• ICD-10 code E29.1
• NDC number for the specific AndroGel formulation requested
• Step therapy documentation if the insurer requires a trial of generic testosterone gel first

Blue Cross Blue Shield of Massachusetts, Harvard Pilgrim, and Tufts Health Plan all require step therapy, meaning the PA will typically be approved for generic testosterone gel before brand-name AndroGel. If you have a clinical reason to avoid the generic (such as a documented allergy to an excipient), the prescriber must document that reason explicitly in the PA request.

The American Urological Association's 2022 guideline on male hypogonadism states: "Clinicians should counsel testosterone deficiency patients regarding the availability of all FDA-approved testosterone formulations and assist patients in accessing the most appropriate and cost-effective treatment." [20] That language is useful to include in PA appeal letters when a plan denies brand-name coverage.

Transferring an Existing AndroGel Prescription to Massachusetts

If you move to Massachusetts or establish Massachusetts residency while already using AndroGel prescribed in another state, the transfer process depends on the prescription format.

Schedule III prescriptions may be transferred between pharmacies one time, and only if both pharmacies use the same computer system or the original pharmacy has not dispensed any refills yet. [5] Because AndroGel is a controlled substance, the practical advice is to have your prescriber in the original state transmit a new prescription electronically to a Massachusetts pharmacy, rather than attempting a formal transfer.

Alternatively, if you are transitioning to a Massachusetts-based prescriber, that prescriber will need to perform their own clinical evaluation. They cannot simply adopt another state's prescription. They will require your previous labs, but they may elect to reorder labs themselves to establish their own clinical baseline before prescribing. Most Massachusetts prescribers who see TRT patients routinely will accept recent lab results (within 6 months) to avoid redundant draws, but this is at their clinical discretion.

Monitoring After Starting AndroGel in Massachusetts

Starting AndroGel is not a set-and-forget intervention. The Endocrine Society guideline specifies monitoring at 3 to 6 months after starting therapy and annually thereafter. [4] The monitoring panel includes total testosterone (drawn 2 to 4 hours after gel application to capture peak levels), hematocrit, PSA (men 40 and older), and a clinical symptom reassessment.

A JAMA Internal Medicine analysis of testosterone prescribing patterns (N=8,880 men) found that only 74.7% of men who started testosterone therapy had a testosterone level checked in the 12 months following initiation, and only 54.2% had hematocrit checked. [21] Both figures fall below the standard of care, and Massachusetts prescribers are expected to document monitoring in the medical record to maintain DEA registration standing.

If hematocrit rises above 54% at any monitoring visit, the prescriber must reduce the AndroGel dose or hold therapy until hematocrit normalizes. [9] Phlebotomy (therapeutic blood donation) is sometimes used as an adjunct, though this is off-label. If PSA rises more than 1.4 ng/mL in any 12-month period, urology referral is warranted before continuing therapy. [4]

Skin transfer is a safety concern specific to testosterone gels. Secondary exposure to female partners or children can cause virilization. [1] The FDA added a black-box warning to all testosterone gel products in 2009 citing reports of virilization in children who had secondary exposure. Patients must wash application sites before contact, cover them with clothing, and wash hands immediately after applying the gel. [1]